Colorectal Cancer Flashcards
Colorectal Cancer - epidemiology
- Third most common cancer in the Western world
- Rare below 40 years of age
- distal colon (recto-sigmoid) more common
- commonly adenocarcinoma
- rarer types include lymphoma, adenosquamous and squamous cell carcinoma
Colorectal cancer - aetiology
- most cases are sporadic (genetic and/or environmental eg obesity)
- genetic = only 5-6% of cases, eg familial adenomatous polyposis (FAP) and Lynch syndrome
Familial adenomatous polyposis (FAP)
- autosomal dominant
- mutation in the adenomatous polyposis coli (APC) tumour suppressor gene
- inherited mutation of one APC allele is followed by a second hit mutation or deletion of the second allele
- multiple (can be thousands) adenomatous polyps in colon with malignant potential (refer for colectomy)
Hereditary non polyposis colorectal cancer (HNPCC) - Lynch syndrome
- mutations in DNA mismatch repair genes (MLH 1, MSH 2)
- more likely to occur in right colon
- a/w other tumours eg endometrial, ovarian, ureteric, small bowel
What is the adenoma –> carcinoma sequence?
- Normal mucosa –> (APC + MLH1/MSH2 + diet, inflammation, hormones) –> 2. Early adenoma –> (K-ras) –> 3. Late adenoma –> (p53) –> 4. adenocarcinoma
adenoma = benign tumour formed from glandular structures in epithelial tissue
Colorectal cancer - risk factors
increasing age APC mutation Lynch syndrome (HNPCC) MYH-associated polyposis hamartomatous polyposis syndromes inflammatory bowel disease (UC > Crohns) obesity smoking
Colorectal cancer - presentation
- older patients
- rectal bleeding
- change in bowel habit (Increased frequency or looser stools, particularly combined with rectal bleeding, is common in left-sided cancers)
- rectal mass
- anaemia (esp right sided colon cancer)
- wt loss
Colorectal cancer - investigations
FBC (anaemia)
liver biochemistry (normal)
renal function (normal unless ureter is compressed)
Faecal Immunochemical Test (FIT) screening. If positive:
1st line - colonoscopy –> ulcerating or exophytic mucosal lesion that may narrow the bowel lumen
(get biopsy if suspicious lesion)
CT scan of thorax, abdomen, and pelvis
- consider double-contrast barium enema or CT colonography as second line
- serum carcinoembryonic antigen (CEA): confirms Dx
(other marker is CA19-9)
- flexible sigmoidoscopy may be appropriate in a low-risk patient, such as isolated rectal bleed in younger pt
Suspected colorectal cancer - 2WW referral (NICE)
Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) if:
- They are aged 40 and over with unexplained weight loss and abdominal pain or
- They are aged 50 and over with unexplained rectal bleeding or
- They are aged 60 and over with:
Iron-deficiency anaemia or
Changes in their bowel habit
- Tests show occult blood in their faeces
Colorectal cancer - red flags
- rectal bleeding
- abdominal pain
- Change in bowel habit
- Weight loss
- Iron-deficiency anaemia
Classification - Primary tumour (T)
T0: No evidence of primary tumour
Tis: only the mucosa (carcinoma in situ)
T1: invades submucosa
T2: invades muscularis propria
T3: invades subserosa but not any neighbouring organs or tissues
T4a: through to the surface of the visceral peritoneum
T4b: directly invades other organs or tissues
Classification - Lymph nodes (N) and mets (M)
N0: No lymph node involvement is found
N1: Metastasis in 1 to 3 regional lymph nodes
N2: Metastasis in 4 or more regional lymph nodes
M0: No distant metastasis
M1: Distant metastasis (1a only 1 organ, 1b more than 1)
Stages based on classification
Stage 0 : Tis, N0, M0 Stage I: T1 or T2, N0, M0 Stage II: T3 or T4, N0, M0 Stage III: T1-T4a, N1 to N2, M0 Stage IV: Any T, any N, M1a or b
Stage determined by contrast‑enhanced CT of the chest, abdomen and pelvis
Dukes’ classification
A: Limited to the bowel wall (submucosa or musc propria)
B: Through the bowel wall (beyond musc propria)
C: Regional lymph nodes metastasis
D: distant metastasis
Management (Colonic)
Stages I-III
- surgical resection (open or laparoscopy)
- postoperative chemotherapy (fluorouracil and folinic acid and oxaliplatin)
Stage IV
- preoperative chemotherapy
- surgical resection
- consider monoclonal antibodies eg bevacizumab
- postoperative chemotherapy
Also need to restore continuity of bowel: anastomosis or end stoma
(Mx is different for rectal cancer)